Skip to main content

Advertisement

SpringerLink
Log in

NELL1-associated membranous nephropathy in lung adenocarcinoma in situ

  • Nephrology – Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

De-identified original data and materials would be provided by the corresponding author upon request.

References

  1. Sethi S, Beck LH Jr, Glassock RJ et al (2023) Mayo clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int 104(6):1092–1102. https://doi.org/10.1016/j.kint.2023.06.032

    Article  CAS  PubMed  Google Scholar 

  2. Caza TN, Hassen SI, Dvanajscak Z et al (2021) NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int 99(4):967–976. https://doi.org/10.1016/j.kint.2020.07.039

    Article  CAS  PubMed  Google Scholar 

  3. Zhou S, Meng F, Yue S, Li H, Zhang L, Wang T (2022) Backtracking cryptic recurrence of esophageal cancer from membranous nephropathy: the detection of glomerular NELL-1 and IgG4. Clin Kidney J 16(4):756–759. https://doi.org/10.1093/ckj/sfac261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mendoza DP, Petranovic M, Som A et al (2022) Lung-RADS category 3 and 4 nodules on lung cancer screening in clinical practice. AJR Am J Roentgenol 219(1):55–65. https://doi.org/10.2214/AJR.21.27180

    Article  PubMed  Google Scholar 

  5. Meirelles GS, Capobianco J, de Oliveira MA (2017) Pitfalls and artifacts in the interpretation of oncologic PET/CT of the chest. Radiol Bras 50(1):55–59. https://doi.org/10.1590/0100-3984.2015.0194

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Graduate School of HeBei Medical University, No. 361 East ZhongShan Boulevard, ShiJiaZhuang, 050011, People’s Republic of China

    ZhiPeng Zhao

  2. Department of Nephrology, The First Hospital of HeBei Medical University, No. 89 DongGang Road, ShiJiaZhuang, 050030, People’s Republic of China

    ZhiPeng Zhao, Jie Feng, LiHong Zhang & Tao Wang

  3. Guangzhou KingMed Center for Clinical Laboratory, No. 10 Spiral the Third Road, GuangZhou, 510005, People’s Republic of China

    ShuLing Yue

  4. TaiYuan KingMed Center for Clinical Laboratory, No. 2 LongSheng Street, TaiYuan, 030000, People’s Republic of China

    Guang Yang

  5. Department of Medical Imaging, The First Hospital of HeBei Medical University, No. 89 DongGang Road, ShiJiaZhuang, 050030, People’s Republic of China

    Chong Liu

  6. Department of Pathology, The First Hospital of HeBei Medical University, No. 89 DongGang Road, ShiJiaZhuang, 050030, People’s Republic of China

    JianZhu Yang

Authors
  1. ZhiPeng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. ShuLing Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. JianZhu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. LiHong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study conception and clinical supervision: TW. Patient care and data acquisition: ZPZ. Tumor staining of NELL1: SLY. Renal pathology: GY and JF. CT and PET-CT image collection and interpretation: CL. General pathology: JZY. Clinical coordination: LHZ. All the authors have reviewed the manuscript and agreed to its publication.

Corresponding author

Correspondence to Tao Wang.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest or financial disclosures.

Ethical approval

The study was approved by the Ethics Committee of the First Hospital of Hebei Medical University (20220744) and conducted in accordance with the CARE Guidelines.

Informed consent

Consent for participation and publication was obtained from the patient.

Use of large language models

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, Z., Yue, S., Yang, G. et al. NELL1-associated membranous nephropathy in lung adenocarcinoma in situ. Int Urol Nephrol (2024). https://doi.org/10.1007/s11255-024-04014-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11255-024-04014-8

Search

Navigation